Risks and characteristics of pancreatic cancer and pancreatic relapse in autoimmune pancreatitis patients

Background and Aim We examined the differences in the risks and characteristics of pancreatic relapse (PR) and pancreatic cancer (PC) in patients with autoimmune pancreatitis (AIP). Methods We retrospectively reviewed 123 type 1 AIP patients with a median follow‐up of 55 months (interquartile range, 27–98). The following items were evaluated: (i) cumulative relapse rates and risk factors, (ii) the incidence of PC, (iii) PR versus PC, and (iv)...